跳至主要内容
临床试验/ITMCTR1900002321
ITMCTR1900002321尚未招募4 期

Clinical study which based on the combination of disease and syndrome to estimating the effects of intervening myocardial remodeling after PCI for coronary heart disease of Tong-Mai Yang-Xin pill

The First Affiliated Hospital of He'nan University of CM0 个研究点开始时间: 待定最近更新:

试验速览

阶段
4 期
状态
尚未招募
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional study

入排标准

年龄范围
18 至 75(—)
性别
All

入选标准

  • 1. The patients with acute anterior myocardial infarction within 10 days, underwent emergency PCI, or underwent PCI after emergency thrombolytic therapy, or received elective PCI within 10 days;
  • 2. The patients meet the syndrome differentiation standard of TCM with Deficient Qi and Yin combined blood stasis;
  • 3. Aged 18 to 75 years, both men and women;
  • 4. Sign the informed consent voluntarily.

排除标准

  • 1. The patients with Multiple coronary artery branches lesions didnt receive elective PCI within 10 days;
  • 2. Acute myocardial infarction with severe complications, such as acute heart failure, cardiogenic shock(conventional treatment cannot correct), or mechanical complication;
  • 3. Acute myocardial infarction with heart failure, Killip classification III or IV;
  • 4. Chronic heart failure or old anterior myocardial infarction in the past medical history;
  • 5. Combined with other diseases, such as cardiomyopathy, rheumatic heart disease, valvular heart disease (Severe stenosis/incomplete closure), arrhythmia (persistent atrial fibrillation/atrial flutter, third degree a-v block, sick sinus syndrome, after implantation of pacemaker) hyperthyroidism, cardiac tamponade, pulmonary arterial hypertensionacute paroxysmal asthma/COPD, severe infection , and so on;
  • 6. Patients with severe liver and kidney function impairment (ALT, AST or TBIL>3 times the upper limit of normal reference value, or Cr >=3mg/dL or eGFR=60ml/min1.73m2); and with severe primary diseases or mental diseases such as hematopoietic system;
  • 7. Patients with malignant tumor;
  • 8. Allergic constitution or allergy to multiple drug or food, allergy to known components of the study drugs;
  • 9. Cannot take care of themselves and cannot receive oral drug;
  • 10. Participated in other drug clinical trials within 1 month;
  • 11. Suspecting or ensuring with a history of substance abuse alcohol or drug abuse;
  • 12. Pregnant or lactating women, or planned pregnancy;
  • 13. According to the judgment of the researcher, the subject is not suitable for involving.

研究者

发起方
The First Affiliated Hospital of He'nan University of CM

相似试验